In vitro antifungal potentials of bioactive compound oleic acid, 3-(octadecyloxy) propyl ester isolated from Lepidagathis cristata Willd. (Acanthaceae) inflorescence  by Abubacker, Maghdu Nainamohamed & Devi, Palaniyappan Kamala
S190
Document heading          doi: 10.1016/S1995-7645(14)60230-3
In vitro antifungal potentials of bioactive compound oleic acid, 
3-(octadecyloxy) propyl ester isolated from Lepidagathis cristata Willd. 
(Acanthaceae) inflorescence
Maghdu Nainamohamed Abubacker1*, Palaniyappan Kamala Devi2
1PG & Research Department of Biotechnology, National College, Tiruchirappalli, India
2Department of Botany, Seethalakshmi Ramasamy College, Tiruchirappalli, India
Asian Pac J Trop Med 2014; 7(Suppl 1): S190-S193
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
    *Corresponding author: Maghdu Nainamohamed Abubacker, Professor and Head, PG 
& Research Department of Biotechnology, National College, Tiruchirappalli-620 001, 
Tamil Nadu, India. 
     Tel: +919894058524   
     E-mail: abubacker_nct@yahoo.com
1. Introduction
 
   Over the centuries, the use of medicinal herbs has 
become an important part of daily life. Approximately 
3 000 plant species are known to have medicinal properties 
in India[1]. In Rig Veda (3700 BC) use of medicinal plants 
as traditional system of medicine is well described. It 
is estimated that 80% of the world population depends 
directly on the plant-based remedies for their health 
care[2]. 
   Lepidagathis cristata Willd. (Acanthaceae) (L. cristata) 
is a medicinal herb. The roots, leaves and inflorescence 
of L. cristata are medicinally useful. The roots of the herb 
are used in stomachic and dyspepsia, leaves are used 
for fevers and the inflorescence ash is used for itchy 
affections of skin and burns[3,4].
   The plant is a stiff herb, and the branches procumbently 
arise from a hard central rootstock. Leaves are alternate, 
elliptic, serrate and usually lineolate. Flowers are sessile, 
capitate, the heads terminal or axillary densely crowed 
at the base of the plant, fruits glucose capsule[5,6]. 
This medicinal herb has been exploited tremendously 
by common people in many ways for various curative 
purposes. It is necessary to evaluate the herb in a 
scientific base for its potential use of folk medicine for the 
treatment of infectious diseases[7]. 
   Antibacterial studies[7,8], pharmacognostical and 
phytochemical  s tudies [9],  analgest ic  and ant i-
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inflammatory activities studies[10], hypoglycaemic activity 
in alloxan induced diabetic rats of L. cristata have been 
documented so far but antifungal activity of this herb 
seems to be lacking[11]. Biological studies are very much 
essential to substantiate the therapeutic properties of 
medicinal herbs used in folk medicine on scientific 
bases[12]. Literature survey on L. cristata revealed that 
the therapeutic properties of this herb had not been 
established so far. Hence an attempt was made in the 
present study to investigate the feasibility of using L. 
cristata against various fungal isolates of both plant and 
human pathogens. 
2. Materials and methods 
2.1. Collection and identification of plant material 
   Fresh plants of L. cristata, Willd. (Acanthaceae) were 
collected from Pachhaimalai Hills, Tiruchirappalli District 
(Figure 1a). The taxonomic identities of the plant were 
confirmed by previously described[5]. The plant material 
was washed under running tap water, air dried in shade 
and then the inflorescence was homogenized to fine powder 
and stored in sterile air tight bottles for the experimental 
use. 
2.2. Fungal cultures 
   The fungal cultures tested in this work Colletotrichum 
fulcatum NCBT 146 (C. fulcatum), Fusarium oxysporum 
NCBT 156 (F. oxysporum) and Rhizoctonia solani NCBT 196 
(R. solani) were maintained in immobilized condition in 
polyurethane foam in Microbiology Lab, Department of 
Biotechnology, National College, Tiruchirappalli, whereas 
Curvularia lunata MTCC 2030 (C. lunata ) and Microsporum 
canis MTCC 2820 (M. canis) were obtained from Microbial 
Type Culture Collection and Gene Bank MTCC, Chandigarh. 
2.3. Experimental procedure 
   Different weight of dry inflorescence power (2 mg, 4 
mg, 6 mg and 12 mg) were mixed with different volume of 
Sabourand dextrose agar (SDA) medium (HI media M063) to 
form different concentrations (100 mg/L, 200 mg/L, 400 mg/
L and 800 mg/L). The Control-1 contained only 20 mL of SDA 
medium and Control-2 contained 2 mg of bavistin fungicide 
added to 20 mL of SDA medium at 100 mg/L concentration. 
The inflorescence powder is mixed with the medium in Petri 
dish (9 cm) and inoculated with 0.5 mL spore suspension of 
fungi prepared from 10 days old culture. The experimental 
Petri dishes were incubated for 8 d at (28依2) °C temperature 
in dark. Three replicates were prepared and inoculated with 
fungal spores for each treatment. 
2.4. Determination of the minimum inhibitory concentration 
(MIC) 
   MIC was determined by the liquid dilution method[13]. 
Dilution series were prepared with 0.25 to 15.00 mg/mL of 
Sabourand dextrose broth medium. To each tube 0.1 mL of 
standardized suspension of fungal spores (4伊106 spores/mL) 
were added and incubated at (28依2) °C for 24 h. The lowest 
concentration which did not show any growth of the tested 
fungi after microscopic evaluation was determined as MIC. 
2.5.  Isolat ion of  bioact ive  compound-thin layer 
chromatography (TLC) 
   Glass plates (4 cm伊12 cm) were used in which 30 g 
silica gel mixed with 60 mL distilled water and slurry was 
prepared and coated on the glass plate to 0.25 cm thickness 
dried for an hour at 110 °C in an air oven[14].
2.6. Preparation of inflorescence extract for bioactive 
compound
   The dry powdered inflorescence (500 mg) of L. cristata was 
mixed with 5.0 mL of chloroform and ground into a paste, 
dried at room temperature. About 1 mL of chloroform was 
added to the dried samples and spotted on the TLC plates. The 
TLC plates were kept in several eluent mixture with different 
polarities to separate the bioactive chemical compounds. The 
eluent used were chloroform: n-hexane (8:2), chloroform: ethyl 
acetate (8:2), chloroform: acetone (8:2), n-hexane: acetone 
(9:1), and chloroform: acetone (9:1). Samples spotting on the 
TLC plate were done by using a micropipette in which the 
dot diameter was 0.5 mm. The chloroform: acetone (9:1) was 
the best eluent since it was able to separate the compounds 
contained in inflorescence extract[15].
2.7. Gas chromatography and mass spectroscopy (GC-MS) 
   GC-MS analyses were performed using a GC Clarus 500 
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Perkin Elmer equipment, equipped with a flame ionization 
detector and injector MS transfer line temperature of 
230 °C, fused silica capillary column Elite-5 MS (5% 
diphenyl/95% dimethyl polysiloxane), 30.00伊0.25 µL df, 
film thickness, carrier gas helium at a flow rate of 28 
cm/s was used. A volume of 1 mL of extract mixed with 
methanol (80%) at a split rate 10:1 was injected[16]. The 
compound identification was accomplished by comparing 
the GC relative retention and mass spectra to those of 
authentic substances analysed under the same conditions, 
by their retention indices and by comparison to reference 
compounds. 
3. Results
 
   The aqueous extract of dried powder of L. cristata 
inflorescence has shown varied antifungal properties 
against both plant pathogenic as well as human pathogenic 
fungi tested in this work (Table 1). The growth of both 
plant and human pathogenic fungal strains were totally 
inhibited at 400 and 800 mg/L concentration respectively. 
The total inhibition can be comparable to Control-2, a 
standard antifungal agent bavistin at 100 mg/L. However 
at 200 mg/L concentration 75% growth inhibition was 
exhibited by C. fulcatum NCBT 146, C. lunata MTCC 2030, 
F. oxysporum NCBT 156 and M. canis MTCC 2820 and a total 
inhibition was noticed for R. solani NCBT 194. At 100 mg/
L concentration 50% growth inhibition was exhibited by 
C. fulcatum, C. lunata and M. canis. F. oxysporum have 
shown 75% growth inhibition and a total inhibition was 
noticed for R. solani at 100 mg/L concentration (Figure 1b-
1f). 
   The MIC values of the aqueous extract of inflorescence 
varied from 4.50 mg/mL to 10.50 mg/mL for the fungi tested. 
The MIC value of R. solani, F. oxysporum, C. fulcatum, C. 
lunata and M. canis were 4.50, 6.50, 8.50, 9.50 and 10.50 
mg/mL respectively. Further investigation was performed 
to demonstrate the action of the extract on these fungi 
at different concentrations. The growth of these fungi 
correspondingly decreased with increasing concentration 
of the extract and the growth was completely inhibited 
at their MIC values. The reduction of growth was possibly 
due to the interference by active principles, i.e., bioactive 
compound olic acid, 3-(octadecyloxy) propyl ester 
(Table 2 and Figure 2). Therefore, the MIC determination 
is important in giving a guideline of the choice of an 
appropriate and effective concentration of antifungal 
therapeutic substance.
Table 1
Antifungal potentials of bioactive compound olic acid, 3-(octadecyloxy) propyl 
ester isolated from inflorescence of L. cristata.
Fungus Control Concentration of the extract
1 2 100 mg/L 200 mg/L 400 mg/L 800 mg/L
C. fulcatum NCBT 146 ++++ - ++ + - -
C. lunata MTCC 2030 ++++ + ++ + - -
F. oxysporum NCBT 156 ++++ + + + - -
M. canis MTCC 2820 ++++ + ++ + - -
R. solani NCBT 194 ++++ - - - - -
Control-1: Medium without inflorescence extract; Control-2: Medium with 
Bavistin (100 mg/L). ++++: Normal growth; +++: 25% growth inhibition; ++: 50% 
growth inhibition; +: 75% growth inhibition; -: Total (100%) growth inhibition.
100 mg/L
100 mg/L 100 mg/L
100 mg/L100 mg/L
800 mg/L
800 mg/L 800 mg/L
800 mg/L800 mg/L
Figure 1. Antifungal activity of bioactive compound oleic acid, 3-(octadecyloxy) 
propyl ester isolated from L. cristata Willd. (Acanthaceae) infloresence.
a: L. cristata plant habit; b: C. fulcatum NCBT 146; c: C. lunata MTCC 2030; d: F. 
oxysporum NCBT 156; e: M. canis MTCC 2820; f: R. solani NCBT 194; C1: Control-1 
(without infloresence extract); C2: Control-2 (Bavistin 100 mg/L). Concentrations of 
infloresence extract ranged from 100 mg/L to 800 mg/L.
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Table 2
Components identified in L. cristata.
RT Name of the compound Molecular 
formula
MW Peak area 
(%)
4.95 Heptadecane,9-hexyl- C23H48 324 34.48
5.54 Octadecane, 3-ethyl-5-(2-ethylbutyl)- C26H54 366 34.48
7.63 Oleic acid, 3-(octadecyloxy) propyl ester C39H76O3 592 31.03
MW: Molecular weight. Parameters tested are not covered under the scope of NABL 
acreditation.
100
%
0
    4.00                 9.00              14.00               19.00                24.00              29.00              34.00
Time
7.63
S.No 714
Sample No: 714
GC-MS Analysis 387
HCPT, Thanjavur, 2-APR-2012 + 16:06:45
Scan EI+
TIC
8.46e7
5.544.952.65
Figure 2. GC-MS chromatogram of L. cristata.
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4. Discussion
   The results of earlier work with L. cristata reveal that the 
plant extract is significantly effective against Gram-positive 
bacteria[7,17,18]. Lepidagathis trinervis plant ashes were used 
to cure eczema[9]. L. cristata, inflorescence ash with oil 
applied externally to cure black patches on face[19]. Review 
of literature reveals lack of information on the antifungal 
potential of L. cristata extract. In the present investigation 
the antifungal activity of its inflorescence has been 
demonstrated for the first time. L. cristata inflorescence 
extract was investigated for its potential bioactive 
compound, olic acid, 3-(octadecyloxy) propyl ester (C39H76O3), 
an effective plant extract and as antifungal agent for plant 
and human pathogenic fungi. 
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